Paracetamol tablets/capsules 500 mg;Valproic acid, tablets, 300 mg each;Azithromycin, powder for oral suspension, 200 mg/5 ml, 30 ml (1200 mg suspension);Enalapril 5 mg tablets;Benzyl benzoate emulsion for the skin, 200 mg/g, 50 g in a bottle;Furosemide, tablets, 40 mg each;Hydrochlorothiazide 25 mg tablets;Complex of iron (III) hydroxide with polymaltose and folic acid, tablets, 100 mg/0.35 mg;Epinephrine 1.82 mg/ml, solution for injection, ampoule;Retinol acetate dermal and oral solution, oily
By: Inna Beshevets📍 UkraineClosed
Key Information
| Reference | GB-UA-2026-09-14-014816-a |
|---|
| Deadline | Sep 17, 2026 12:00 AM |
|---|
| Estimated Value | UAH 61,640,187.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 50074, Ukraine, Dnipropetrovsk region, Kryvyi Rih, str.Sviatogeorhiivska, 8a |
|---|
| Published | Sep 14, 2026 |
|---|
Description
Paracetamol tablets/capsules 500 mg;Valproic acid, tablets, 300 mg each;Azithromycin, powder for oral suspension, 200 mg/5 ml, 30 ml (1200 mg suspension);Enalapril 5 mg tablets;Benzyl benzoate emulsio...
Full details are available after unlocking this tender.